Sector dividends Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.89 USD | +0.52% |
|
+7.57% | -17.72% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 33.41x | 2.2x | 2.46x | 10.13x | 12.67x | 7.42B | ||
| 0.85% | 0.98% | 39.91x | 4.14x | 5.79x | 20.28x | 29.12x | 49.72B | ||
| -.--% | -.--% | 21.18x | 4.13x | 2.48x | 10.53x | 12.44x | 27.48B | ||
| 0.44% | 0.45% | 41.87x | 2.02x | 8.57x | 25.22x | 31.29x | 26.19B | ||
| 1.16% | 1.29% | 22.42x | 2.04x | 1.9x | 8.6x | 13.87x | 12.3B | ||
| -.--% | -.--% | -46.64x | 47.5x | 10.28x | 2381.3x | -231.45x | 12.25B | ||
| -.--% | -.--% | 15.63x | 1.17x | 1.78x | 8.95x | 9.83x | 11.57B | ||
| -.--% | -.--% | -2.75x | 1.36x | 2.58x | -1.36x | -1.3x | 10.73B | ||
| -.--% | -.--% | -37.12x | -49.17x | 15.42x | -47.69x | -43.24x | 10.37B | ||
| 0.11% | 0.11% | 24.39x | 2.72x | 5.08x | 13.57x | 16.9x | 10.12B | ||
| -.--% | -.--% | 23.72x | 10.34x | 3.77x | 17.28x | 18.37x | 8.69B | ||
| 0.26% | 0.26% | -174.14x | 23.88x | 11.39x | -129.59x | -109.17x | 8.27B | ||
| 0.62% | 0.65% | 51.99x | 3.98x | 6.74x | 19.36x | 21.43x | 8.08B | ||
| -.--% | -.--% | -8.65x | 5.17x | 4108.91x | -6.31x | -6.29x | 7.6B | ||
| 0.57% | 0.71% | 43.64x | 2.04x | 6.04x | 27.16x | 32.42x | 5.98B | ||
| 0.84% | 0.97% | 24.34x | 2.83x | 3.22x | 12.96x | 20.75x | 5.77B | ||
| -.--% | -.--% | -11.76x | 26.66x | 6.72x | -10.54x | -10.67x | 5.76B | ||
| -.--% | -.--% | 46.93x | 12.48x | 6.89x | 44.51x | 44.6x | 5.64B | ||
| Average | 0.27% | 0.3% | 6.02x | 5.86x | 233.89x | 133.58x | -7.69x | 13B | |
| Weighted average by Cap. | 0.36% | 0.41% | 14.30x | 4.93x | 139.10x | 131.08x | -1.09x |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition